In the vast majority of cases light-chain (AL) or transthyretin (ATTR) amyloid deposits are responsible for CA, leading to systolic and diastolic dysfunction, hypertrophy, arrhythmias, conduction blocks, and heart failure. This evidence concerns the gene TTR and heart failure.